China could ‘corner’ biopharmaceutical sector with new plan, US panel warns
A commission called on U.S. lawmakers to act quickly to prevent an “overdependence” on China that could leave American patients “vulnerable to supply chain weaponization.”
We haven't written up this one. BioPharma Dive has the full story — the link below goes straight to it.